Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models
Authors:
- Carlos A. MatosCMCarlos A. Matos
- Clévio NóbregaCNClévio Nóbrega
- Susana R. LourosSLSusana R. Louros
- Bruno AlmeidaBABruno Almeida
- Elisabete FerreiroElisabete Ferreiro
- Jorge ValeroJVJorge Valero
- Luís Pereira de AlmeidaLALuís Pereira de Almeida
- Sandra Macedo-RibeiroSMSandra Macedo-Ribeiro
- Ana Luísa CarvalhoACAna Luísa Carvalho
Open Access
- 15 February 2016
- journal article
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 212 (4) , 465-480
Abstract
Different neurodegenerative diseases are caused by aberrant elongation of repeated glutamine sequences normally found in particular human proteins. Although the proteins involved are ubiquitously distributed in human tissues, toxicity targets only defined neuronal populations. Changes caused by an expanded polyglutamine protein are possibly influenced by endogenous cellular mechanisms, which may be harnessed to produce neuroprotection. Here, we show that ataxin-3, the protein involved in spinocerebellar ataxia type 3, also known as Machado-Joseph disease, causes dendritic and synapse loss in cultured neurons when expanded. We report that S12 of ataxin-3 is phosphorylated in neurons and that mutating this residue so as to mimic a constitutive phosphorylated state counters the neuromorphologic defects observed. In rats stereotaxically injected with expanded ataxin-3–encoding lentiviral vectors, mutation of serine 12 reduces aggregation, neuronal loss, and synapse loss. Our results suggest that S12 plays a role in the pathogenic pathways mediated by polyglutamine-expanded ataxin-3 and that phosphorylation of this residue protects against toxicity.Keywords
Funding Information
- Portuguese Science and Technology Foundation (PTDC/SAU-NMC/110602/2009, PEst-C/SAU/LA0001/2013-2014, UID/NEU/04539/2013)
- Portuguese Science and Technology Foundation (SFRH/BD/47160/2008, SFRH/BPD/70783/2010)
This publication has 73 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Pathogenic polyglutamine proteins cause dendrite defects associated with specific actin cytoskeletal alterations in DrosophilaProceedings of the National Academy of Sciences, 2011
- Crystal Structure of a Josephin-Ubiquitin ComplexJournal of Biological Chemistry, 2011
- Machado-Joseph Disease: from first descriptions to new perspectivesOrphanet Journal of Rare Diseases, 2011
- Activity and Cellular Functions of the Deubiquitinating Enzyme and Polyglutamine Disease Protein Ataxin-3 Are Regulated by Ubiquitination at Lysine 117Journal of Biological Chemistry, 2010
- Functional interactions as a survival strategy against abnormal aggregationThe FASEB Journal, 2010
- Silencing ataxin-3 mitigates degeneration in a rat model of Machado–Joseph disease: no role for wild-type ataxin-3?Human Molecular Genetics, 2010
- Phosphorylation of Threonine 3Journal of Biological Chemistry, 2009
- The Chemical Biology of Protein PhosphorylationAnnual Review of Biochemistry, 2009
- Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph DiseasePLOS ONE, 2008